Drug-Drug Interaction Study: ASP2151 and Ritonavir

NCT02223351 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ASP2151
DRUG: ritonavir

Sponsor

Maruho Europe Limited